Evidence map›Paper›PMID 25103824›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2014

Polymorphisms in MicroRNAs are associated with survival in non-small cell lung cancer.

Yang Zhao, Qingyi Wei, Lingming Hu, Feng Chen, Zhibin Hu, Rebecca S Heist, Li Su, Christopher I Amos, Hongbing Shen, David C Christiani

Abstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. MiRNAs and miRNA Polymorphisms Modify Drug Response.International journal of environmental research and public health · 2016
    Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yang ZhaoNanjing Medical University, Nanjing, China.
Qingyi WeiDuke Cancer Institute, Duke University, Durham, North Carolina.
Lingming HuNanjing Medical University, Nanjing, China.
Feng ChenNanjing Medical University, Nanjing, China.
Zhibin HuNanjing Medical University, Nanjing, China.
Rebecca S HeistMassachusetts General Hospital, Boston, Massachusetts.
Li SuHarvard School of Public Health, Boston, Massachusetts.
Christopher I AmosGeisel School of Medicine, Dartmouth College, Lebanon, New Hampshire.
Hongbing ShenNanjing Medical University, Nanjing, China.
David C ChristianiNanjing Medical University, Nanjing, China. Massachusetts General Hospital, Boston, Massachusetts. Harvard School of Public Health, Boston, Massachusetts. dchris@hsph.harvard.edu.

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Steven D Leach · 1985 to 2026
$91.3M
Translational Research Support CoreP30ES000002 · NIEHS · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI SUSAN A KORRICK · 1985 to 2026
$44.6M
Translational studies of Hsp90 inhibitors in NSCLCP50CA090578 · NCI · DANA-FARBER CANCER INST · PI JOHNSON, BRUCE D · 2008 to 2012
$11.4M
Quantitative Biology Research InstituteP20GM103534 · NIGMS · DARTMOUTH COLLEGE · PI AMOS, CHRISTOPHER I. · 2012 to 2016
$8.6M
Molecular and Genetic Analysis of Lung Cancer SurvivalR01CA092824 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI CHRISTIANI, DAVID C · 2002 to 2013
$5.9M
NCI NIH HHS 5R01CA092824NCI NIH HHS P30 CA023108NCI NIH HHS P50 CA090578NCI NIH HHS P50CA090578NCI NIH HHS R01 CA092824NCI NIH HHS R01CA092824NIEHS NIH HHS P30 ES000002NIEHS NIH HHS P30ES000002NIGMS NIH HHS P20 GM103534
6 · The paper itself

Abstract

backgroundMicroRNAs (miRNA) play important roles in the regulation of eukaryotic gene expression and are involved in human carcinogenesis. Single-nucleotide polymorphisms (SNP) in miRNA sequence may alter miRNA functions in gene regulation, which, in turn, may affect cancer risk and disease progression.

methodsWe conducted an analysis of associations of 142 miRNA SNPs with non-small cell lung cancer (NSCLC) survival using data from a genome-wide association study (GWAS) in a Caucasian population from the Massachusetts General Hospital (Boston, MA) including 452 early-stage and 526 late-stage NSCLC cases. Replication analyses were further performed in two external populations, one Caucasian cohort from The University of Texas MD Anderson Cancer Center (Houston, TX) and one Han Chinese cohort from Nanjing, China.

resultsWe identified seven significant SNPs in the discovery set. Results from the independent Caucasian cohort demonstrated that the C allele of rs2042253 (hsa-miRNA-5197) was significantly associated with decreased risk for death among the patients with late-stage NSCLC (discovery set: HR, 0.80; P = 0.007; validation set: HR, 0.86; P = 0.035; combined analysis: HR, 0.87; P = 0.007).

conclusionsThese findings provide evidence that some miRNA SNPs are associated with NSCLC survival and can be used as predictive biomarkers. IMPACT: This study provided an estimate of outcome probability for survival experience of patients with NSCLC, which demonstrates that genetic factors, as well as classic nongenetic factors, may be used to predict individual outcome.

Indexed as

AgedCarcinoma, Non-Small-Cell LungFemaleGenome-Wide Association StudyHumansLung NeoplasmsMaleMicroRNAsPolymorphism, GeneticPolymorphism, Single NucleotidePrognosisMicroRNAs

Identifiers

PMID25103824
PMCPMC4221531

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.